Aphria RX, a subsidiary of Tilray Brands, launched the first commercial medical cannabis flower grown at its facility in Neumünster, Germany.
The launch marks the first medical marijuana products that Aphria RX has grown under the MMJ cultivation license the company received in July under Germany’s Medicinal Cannabis Act (MedCanG), according to a Thursday news release.
ADVERTISEMENT
The license allows Aphria RX to cultivate and manufacture a range of commercially available medical cannabis in Germany.
Denise Faltischek, Tilray’s chief strategy officer and head of international, said the launch expands Tilray’s presence in medical cannabis cultivation, production and distribution in Germany.
“We reiterate our appreciation for the trust that the German government has placed in Tilray, and we are proud of our Aphria RX
Read full article on Marijuana Business Daily
